tiprankstipranks
Sonnet BioTherapeutics announces updated clinical data for SON-1010
PremiumThe FlySonnet BioTherapeutics announces updated clinical data for SON-1010
2M ago
Sonnet BioTherapeutics price target lowered to $7 from $11 at EF Hutton
PremiumThe Fly
Sonnet BioTherapeutics price target lowered to $7 from $11 at EF Hutton
2M ago
Sonnet Biotherapeutics Holdings, Inc. (SONN) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Sonnet Biotherapeutics Holdings, Inc. (SONN) Q2 Earnings Cheat Sheet
2M ago
Sonnet BioTherapeutics reports Q1 EPS (31c) vs. ($17.62) last year
PremiumThe FlySonnet BioTherapeutics reports Q1 EPS (31c) vs. ($17.62) last year
5M ago
SONN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
SONN Earnings this Week: How Will it Perform?
5M ago
Sonnet BioTherapeutics Regains Compliance, Risks Nasdaq Delisting
PremiumCompany Announcements
Sonnet BioTherapeutics Regains Compliance, Risks Nasdaq Delisting
5M ago
Sonnet BioTherapeutics sees cash runway into 3Q24
PremiumThe FlySonnet BioTherapeutics sees cash runway into 3Q24
8M ago
Sonnet prices 2.84M shares at $1.60 in underwritten public offering
PremiumThe Fly
Sonnet prices 2.84M shares at $1.60 in underwritten public offering
8M ago
Sonnet announces results of biodistribution studies using FHAB technology
PremiumThe Fly
Sonnet announces results of biodistribution studies using FHAB technology
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100